NCT00207636 Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening Status COMPLETED Phase NA
NCT00207259 Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial Status COMPLETED Phase NA
NCT00203424 Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib Status COMPLETED Phase PHASE2
NCT00201916 Shorter Radiation Schedule for the Treatment of Prostate Cancer Status COMPLETED Phase PHASE3
NCT00201630 Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy Status UNKNOWN Phase PHASE3
NCT00200824 Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health Status COMPLETED Phase PHASE2
NCT00200187 A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery Status COMPLETED Phase PHASE2
NCT00199537 Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer Status COMPLETED Phase N/A
NCT00199485 Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer Status COMPLETED Phase PHASE4
NCT00196339 A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients Status COMPLETED Phase PHASE2
NCT00195039 Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00193856 RADAR Trial - Randomised Androgen Deprivation and Radiotherapy Status COMPLETED Phase PHASE3
NCT00193271 Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer Status COMPLETED Phase PHASE2
NCT00193232 Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT00193193 Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma Status COMPLETED Phase PHASE2
NCT00188383 Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy Status UNKNOWN Phase PHASE1/PHASE2